Organic vs Inorganic Growth
Organic vs inorganic growth is the distinction between revenue a company generates from its existing business — selling more units, raising prices, gaining share, launching products — versus revenue it buys by acquiring or merging with other companies. The core tension for an analyst is one of quality and durability: a top-line growth rate of, say, 15% can be the output of a genuinely thriving core business, or it can be a financial illusion stitched together from serial acquisitions that mask a stagnant or shrinking underlying operation. The two look identical on the revenue line and very different on returns, free cash flow, and the balance sheet. Decomposing growth into its organic and inorganic parts is one of the highest-leverage moves in growth analysis.
How it's calculated / formed
There is no single statutory definition. "Organic revenue growth" is a non-GAAP measure, and the SEC requires companies that present it to reconcile it to GAAP revenue and describe the methodology (SEC Financial Reporting Manual, Topic 8). The standard construction:
- Reported (GAAP) growth = total YoY change in revenue.
- Inorganic contribution = revenue from businesses acquired (or lost to divestitures) that were not in the base period. The common convention is to exclude incremental revenue from current-year acquisitions, and to "annualize" prior-year acquisitions so the comparison is like-for-like once a deal has been owned for a full year.
- FX contribution = the effect of currency translation. "Constant-currency" or "organic, constant-currency" growth restates foreign revenue at prior-period exchange rates (Deloitte DART, §4.13).
- Organic growth = Reported growth − acquisitions/divestitures − FX (and sometimes ± other one-offs).
Sector analogues exist: same-store / comparable-store sales ("comps") in retail and restaurants strip out new and closed locations to isolate the growth of the existing base, and same-store sales built purely from GAAP revenue are not themselves a non-GAAP measure. The mechanics differ but the intent is identical — separate growth of the core from growth bought with capital.
Because the carve-out boundary is a management judgment call (what counts as "core," how long an acquisition stays "inorganic," which items are "one-off"), organic-growth figures are not perfectly comparable across companies and are a known target for adjustment games.
How it's used in practice
Analysts decompose the headline number first, then judge the mix:
- Quality of growth. Organic growth signals product-market fit, pricing power, and share gains funded by retained earnings. Acquired growth signals that capital — often debt or dilutive stock — was deployed to buy a top line.
- Sustainability and reinvestment runway. Organic growth tends to compound on itself; acquisitive growth requires an ever-larger stream of targets to maintain the same percentage rate (the "treadmill" problem for serial acquirers).
- Returns lens. The decisive question is return on invested capital. Buying growth means paying the standalone value of the target plus a control premium, which structurally pressures ROIC unless synergies exceed the premium. Organic growth carries no premium.
- Red-flag screen. Strong reported growth + weak or negative organic growth + rising goodwill/intangibles + rising leverage is a classic "roll-up under stress" pattern. Heavy reliance on acquisitions can also obscure deteriorating core demand and complicate cash-flow analysis (acquisition spend sits in investing, not operating, cash flow).
In practice neither is "good" or "bad" in isolation — the analyst is checking that the chosen growth engine actually earns its cost of capital.
Adoption, debate & evidence
The organic/inorganic split is universal in equity research, investor presentations, and M&A advisory; it is taught as standard fundamental analysis. The genuinely contested part is the efficacy claim — "organic is better."
- The case for organic. McKinsey's analysis of ~550 US and European companies over ~15 years found that, at comparable revenue-growth levels, companies relying more on organic growth delivered higher shareholder returns than those relying more on acquisitions, attributed largely to not paying acquisition premiums and thus earning higher ROIC ("The value premium of organic growth," McKinsey). The frequently cited "most acquisitions fail to create value" figure (often quoted as roughly 60–70%+, attributed to Harvard Business Review and various studies) supports the same skepticism toward inorganic growth.
- The important nuance. "Acquisitive" is not monolithic. McKinsey's M&A work finds that programmatic acquirers — companies making many small, repeatable deals — outperform: roughly 2% more excess total shareholder return annually than peers, with about 65% generating positive excess TRS, whereas large-deal ("big bet"), selective, and organic-only approaches produced no excess TRS on average in that dataset (large deals carry the widest dispersion of outcomes — roughly a coin flip rather than a reliable strategy) ("A programmatic approach to M&A is more likely to create value," McKinsey). So the evidence is not "organic beats M&A" flatly — it is "premium-paying, lumpy M&A destroys value on average, while disciplined serial M&A can be the strongest strategy of all."
The honest summary: organic growth is, on average, higher-quality per unit; but the best-run programmatic acquirers are the documented exception, and analysts should not reflexively penalize all inorganic growth.
Strengths & limitations
The framework's strength is that it forces a quality check that the revenue line alone hides — it is genuinely one of the most useful decompositions in fundamental analysis. Its main limitations: (1) the organic figure is non-GAAP and management-defined, so it can be massaged — the #1 misuse is treating a company's self-reported "organic" number as objective truth rather than rebuilding it and inspecting the carve-out assumptions; (2) acquisition accounting (purchase-price allocation, deferred-revenue write-downs, goodwill) can distort the base for a year or more, making "organic" measurement noisy right after deals; and (3) the "organic = good" heuristic is an average, not a law, and misclassifies skilled programmatic acquirers. It works best as one input into a returns-on-capital judgment, not as a standalone verdict.
Sources
- SEC, Financial Reporting Manual, Topic 8 (Non-GAAP Measures) — https://www.sec.gov/about/divisions-offices/division-corporation-finance/financial-reporting-manual/frm-topic-8
- Deloitte DART, Roadmap to Non-GAAP Measures §4.13 (Constant Currency Presentations) — https://dart.deloitte.com/USDART/home/accounting/sec/sec-reporting-interpretations-manual/roadmap-non-gaap-financial-measures/chapter-4-non-gaap-measures-that/4-13-constant-currency-presentations
- McKinsey, "The value premium of organic growth" (~550 companies, ~15 years; organic > acquisitive at comparable growth) — https://www.mckinsey.com/capabilities/strategy-and-corporate-finance/our-insights/the-value-premium-of-organic-growth
- McKinsey, "A programmatic approach to M&A is more likely to create value than all others" (~2% excess TRS; ~65% positive; large deals ~coin flip) — https://www.mckinsey.com/capabilities/strategy-and-corporate-finance/our-insights/how-one-approach-to-m-and-a-is-more-likely-to-create-value-than-all-others
- McKinsey, "The granularity of growth" (decomposition into portfolio momentum, M&A, market-share performance) — https://www.mckinsey.com/featured-insights/employment-and-growth/the-granularity-of-growth
- Investopedia / Preferred CFO / PCE Companies — general definitions and integration-cost context (flagged: the "~60% of acquisitions fail" figure is widely cited but estimates vary by study and definition of "success")
Dispute flagged: the popular claim that "organic growth beats M&A" is true on average per McKinsey's value-premium study but is contradicted for the specific subset of disciplined programmatic acquirers — treat as a quality presumption, not a rule.